Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Alkermes plc
  6. News
  7. Summary
    ALKS   IE00B56GVS15

ALKERMES PLC

(ALKS)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Alkermes : BofA Securities Downgrades Alkermes to Underperform from Neutral on Risk/Reward, Valuation; Sets $27 Price Target

09/02/2021 | 12:08pm EDT


ę MT Newswires 2021
All news about ALKERMES PLC
10/27Health Care Stocks Slide Wednesday as Biotechs Weigh on Sector
MT
10/27Health Care Stocks Drifting Lower This Afternoon
MT
10/27Alkermes Posts Lower Q3 Adjusted Earnings, Revenue Gains; Reaffirms 2021 Outlook
MT
10/27ALKERMES PLC. Management's Discussion and Analysis of Financial Condition and Results ..
AQ
10/27Q3 2021 Earnings slides 10 26 21 FINAL_v3.pdf
PU
10/27ALKERMES : Q3 Earnings Snapshot
AQ
10/27Alkermes plc Reports Third Quarter 2021 Financial Results - Form 8-K
PU
10/27ALKERMES PLC. : Results of Operations and Financial Condition (form 8-K)
AQ
10/27Earnings Flash (ALKS) ALKERMES Posts Q3 EPS $0.14, vs. Street Est of $0.10
MT
10/27Alkermes plc Reports Third Quarter 2021 Financial Results
PR
More news
Analyst Recommendations on ALKERMES PLC
More recommendations
Financials (USD)
Sales 2021 1 171 M - -
Net income 2021 -72,7 M - -
Net cash 2021 425 M - -
P/E ratio 2021 -64,8x
Yield 2021 -
Capitalization 4 622 M 4 622 M -
EV / Sales 2021 3,58x
EV / Sales 2022 3,10x
Nbr of Employees 2 245
Free-Float 96,4%
Chart ALKERMES PLC
Duration : Period :
Alkermes plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ALKERMES PLC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 8
Last Close Price 28,65 $
Average target price 29,38 $
Spread / Average Target 2,53%
EPS Revisions
Managers and Directors
Richard F. Pops Chairman & Chief Executive Officer
Iain Michael Brown Senior VP, Chief Financial & Accounting Officer
Craig C. Hopkinson Chief Medical Officer & EVP-Research & Development
Thomas Harvey Chief Information Officer & Senior VP-IT
Sondra Smyrnios Senior Vice President-Clinical Operations
Sector and Competitors
1st jan.Capi. (M$)
ALKERMES PLC43.61%5 084
MODERNA, INC.226.29%139 557
LONZA GROUP AG32.63%60 898
IQVIA HOLDINGS INC.41.93%48 923
SEAGEN INC.-0.30%32 330
CELLTRION, INC.-39.00%26 036